Bruker motion backfires in US patent dispute with 10x Genomics, Harvard
A US judge has reconsidered sua sponte his December 2024 disallowance of amended final infringement contentions by 10x Genomics, giving the American biotech company the go-ahead to argue users of an...To view the full article, register now.
Already a subscriber? Click here to view full article